Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Jurata Thin Film
AddedFeb 17, 2024
UpdatedJun 18, 2026
Jurata Thin Film

Jurata Thin Film

Jurata Thin Film enables room temperature storage and versatile delivery of vaccines and biologics.

HQ
Chapel Hill, NC, US
Founded
2019
Overview
Compare
Fundraising
Employees
Website

Founded with the mission to revolutionize the manufacturing, storage, and delivery of vaccines and biologics, Jurata Thin Film focuses on enabling long-term storage at ambient or elevated temperatures. Their innovative thin film technology allows for versatile administration routes, making vaccines and therapeutics more accessible globally. By addressing the critical challenges of vaccine stability and distribution, Jurata aims to enhance public health outcomes worldwide.

Jurata Thin Film's team comprises experts with extensive experience in developing cutting-edge technologies. The company has garnered attention for its potential to transform vaccine logistics, particularly in regions lacking cold chain infrastructure. Notable achievements include successful stabilization of various biologics, positioning Jurata as a key player in the biotech industry. Their impact is significant, promising to improve vaccine accessibility and efficacy on a global scale.

Jurata Thin Film - Similar Companies

VitriVax logo

VitriVax

vitrivaxbio.com

TheraJect logo

TheraJect

Upkara logo

Upkara

upkara.com

Vivebio logo

Vivebio

Innovac Therapeutics logo

Innovac Therapeutics

innovactx.com

Micron Biomedical logo

Micron Biomedical

Uvax Bio logo

Uvax Bio

uvaxbio.com

Jura Bio logo

Jura Bio

jurabio.com

Judo Bio logo

Judo Bio

Vaxess Technologies logo

Vaxess Technologies

vaxess.com

VaxEquity logo

VaxEquity

Granata Bio logo

Granata Bio

granata.bio

Vitranu logo

Vitranu

vitranu.com

Vaxxinity logo

Vaxxinity

vaxxinity.com

Jupiter Therapeutics logo

Jupiter Therapeutics

Jurata Thin Film - Quick Facts

Who are Jurata Thin Film's competitors?

Companies similar to Jurata Thin Film include VitriVax, TheraJect, Upkara and Vivebio.

When was Jurata Thin Film founded?

Jurata Thin Film was founded in 2019.

Where is Jurata Thin Film's headquarters located?

Jurata Thin Film's headquarters is located in Chapel Hill, NC, US.

How much has Jurata Thin Film raised to-date?

As of Sep 19, 2023, Jurata Thin Film has raised a total of $4.9M (USD).

How many employees does Jurata Thin Film have?

Jurata Thin Film has 7 employees as of Feb 4, 2024.

Jurata Thin Film - Classification

Ownership
  • Venture Capital
Technology
  • Biotech
Geographic Exposure
  • Global
Revenue
  • Licensing
  • Recurring
  • Software
Customer
  • Enterprise
  • Government
Main Product
  • Biologics
  • Vaccines
Tags
  • Healthtech
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541500Computer Systems Design and Related Services
  • 541000Professional, Scientific, and Technical Services
  • 541510Computer Systems Design and Related Services
  • 541511Custom Computer Programming Services
SIC
  • 7300Business Services
  • 7370Computer Programming, Data Processing, And Other Computer Related
  • 7371Computer Programming Services
Show 5 more industry codes
NAICS
  • 513200Software Publishers
  • 510000Information
  • 513000Publishing Industries
  • 513210Software Publishers
SIC
  • 7372Prepackaged Software